(1) Dr. John Campbell reviews two recent studies that show pretty convincingly that zinc deficiency is correlated to severity of COVID19.
He attributes the lack of interest in this work as “there’s no money in it, since zinc and vitamin D supplements are dirt cheap to produce”. (Actually, the lack of interest is not universal: Israeli HMOs are now telling dietitians to recommend vitamin D supplements to the entire population. They are not [yet] doing this for zinc.)
I remember picking up a biochemistry textbook to see what processes zinc plays a role in, and eventually concluding, “OK, I should have asked instead which processes it’s not involved in”.
(2) Dr. Seheult reviews recent studies on Remdesivir. I would have changed the title to “… may not work in patients sick enough to require hospitalization”
While there appears to be some indication it might do some good when administered early (as it was to US President Trump), the WHO “Solidarity Trial” on hospitalized patient shows no statistically significant therapeutic benefit. Actually, this is more or less what I’d expect with our current understanding of the disease: by the time patients are sick enough to require ventilation, the real enemy is no longer the virus but the patient’s own immune system. Look in the graph below at “low-flow O2” vs. the other options. (“No O2” was too few hospitalized patients to gather statistically significant data on.)
(3) a quick update on Israel: we are exiting lockdown tomorrow morning. Our epidemiological stats continue to trend in the right direction:
And finally, active infections (=verified – cured – deceased)